InChI=1S/C23H40O3/c1- 2- 3- 4- 5- 6- 7- 8- 9- 10- 11- 12- 13- 14- 15- 16- 17- 18- 19- 20- 26- 23(21- 24) 22- 25/h6- 7,9- 10,12- 13,15- 16,23- 25H,2- 5,8,11,14,17- 22H2,1H3/b7- 6- ,10- 9- ,13- 12- ,16- 15- |
CUJUUWXZAQHCNC-DOFZRALJSA-N |
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCOC(CO)CO |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via endocannabinoid )
cannabinoid receptor agonist
An agonist that binds to and activates cannabinoid receptors.
(via cannabinoid )
|
|
View more via ChEBI Ontology
2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraen-1-yloxy]propane-1,3-diol
|
(5Z,8Z,11Z,14Z)-icosatetraenyl-2-glyceryl ether
|
SUBMITTER
|
2-(5Z,8Z,11Z,14Z-eicosatetraenyl)-sn-glycerol
|
LIPID MAPS
|
2-AG ether
|
LIPID MAPS
|
2-arachidonyl glycerol ether
|
ChEBI
|
2-O-(5Z,8Z,11Z,14Z)-eicosatetraenylglycerol
|
UniProt
|
5Z,8Z,11Z,14Z-eicosatetraen-2-glyceryl ether
|
LIPID MAPS
|
noladin ether
|
LIPID MAPS
|
222723-55-9
|
CAS Registry Number
|
HMDB
|
8798140
|
Reaxys Registry Number
|
Reaxys
|
11259648
|
PubMed citation
|
Europe PMC
|
22309979
|
PubMed citation
|
Europe PMC
|
22728691
|
PubMed citation
|
Europe PMC
|
23386378
|
PubMed citation
|
Europe PMC
|
|